Experience of nevirapine use in a London cohort of HIV-infected pregnant women
Open Access
- 1 April 2001
- journal article
- research article
- Published by Wiley in HIV Medicine
- Vol. 2 (2) , 89-91
- https://doi.org/10.1046/j.1468-1293.2001.00059.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Pharmacological implications of lengthened in-utero exposure to nevirapineThe Lancet, 2000
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infectionClinical Therapeutics, 1998
- The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta‐analysisBJOG: An International Journal of Obstetrics and Gynaecology, 1998
- Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 InfectionAnnals of Internal Medicine, 1996
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994